Fellow Committee
Lei Deng, MD (Chair)
Dr. Lei Deng is a fellow in hematology and oncology at Roswell Park Comprehensive Cancer Center, Buffalo, NY. He received an MD from West China School of Medicine at Sichuan University in China. Additionally, He spent 2 years completing research at Dr. Martin Brown's laboratory at Stanford University, focusing on the impact of tumor irradiation on the phenotypic and functional polarization of monocytes.
Early as a medical student, he was inspired by Tony Mok, MD, to be a thoracic oncologist, when he was a visiting medical student at his clinic. Dr. Deng was a 2016 editorial fellowship recipient of Journal of Global Oncology (now JCO Global Oncology), and has served on the editorial board of JCO Global Oncology since 2019. Through years of his research endeavors, he has published over 40 papers with more than 1500 citations. He is interested in clinical and translational thoracic research focusing on novel biomarkers and therapeutics.
Changchuan (Charles) Jiang, MD, MPH (Co-Chair)
Dr. Changchuan (Charles) Jiang is an active researcher with a strong interest in patient-oriented care, and health service research related to cancer patients. His works led into insight on cancer survivorship symptom and comorbidity burden as well as transportation barriers. His works were published on Lancet Oncology, JAMA Oncology, JNCI and other international journals and were widely reported by CA a cancer journal for clinicians, ASCO Post, NEJM Journal Watch, Cancer, and Medscape. His works were also presented at several international conferences including ASCO, ASCO GU Symposium, and ASCO Quality Care Symposium. Notably, he won the ASCO Conquer Cancer Merit Award 3 times since the fellowship started.
Dr. Jiang graduated with honors from Soochow University, Medical College in China. After that, he earned a Master of Public Health in Epidemiology from Yale University, CT. He finished the residency at the Icahn School of Medicine at Mt Sinai, Mt Sinai St Luke’s/West, and decided to pursue oncology after rotations at Memorial Sloan Kettering Cancer Center. Dr. Jiang is currently a fellow physician in the Medical Oncology/Hematology Program at Roswell Park Comprehensive Cancer Center.
Xiaolin Zhu, MD, PhD
Xiaolin completed a seven-year clinical medicine program at Shanghai Jiao Tong University School of Medicine, including two years studying endocrinology under Dr. Guang Ning at Ruijin Hospital. He then moved to the US for graduate school and obtained a PhD in genetics and genomics, training with prominent geneticist David Goldstein, at Duke and then Columbia University. Motivated to become a physician-scientist, he went back for clinical training and completed his internal medicine residency at UT Southwestern.
Xiaolin has been a hematology/oncology fellow at UCSF since 2020. His clinical interest is genitourinary medical oncology. As an advanced fellow, he is part of the GU medical oncology group at UCSF and conducting translational genomics research in Felix Feng and David Quigley's labs. He is particularly excited about our increasing ability to deeply and serially profile human biospecimens to understand real-time, patient-specific disease biology that enables precision medicine. He has received the Young Investigator Awards from both the American Society of Clinical Oncology (ASCO) and the Prostate Cancer Foundation (PCF).
Chen Zhang, MD
Dr. Zhang is an active clinical investigator in hematologic malignancy, especially lymphoma. He graduated from Shanghai Jiao Tong University School of Medicine and completed his Internal Medicine residency training at the University of Miami/JFK Medical Center. He worked as an internist for three years after residency, during which he obtained a master's degree in clinical research at Rush University. Currently, he is a Hematology/Oncology fellow at Rush University Medical Center.
Shortly after starting residency, Dr. Zhang was inspired by Dr. Shachar Peles during his Hem/Onc electives and decided to pursue a career in hematology. His research was published at the ASCO and ASH annual meetings. He currently participates in multiple clinical research projects and focuses on research in lymphoma.